ストックスクリーナーアプリを入手
319.49
0.24%
0.76
Penumbra Inc (PEN) 最新ニュース
Penumbra Releases Results of CAVT System Study for Stroke Patients - dicardiology.com
Penumbra Inc (PEN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Penumbra Inc (PEN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Penumbra Inc (PEN) Income Statement - TradingKey
Penumbra Inc (PEN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Penumbra Inc (PEN) Cash Flow - TradingKey
Penumbra Inc (PEN) Valuation: PE, PB & Fair Value Analysis - TradingKey
PEN|Penumbra Inc|Price:318.730|Chg%:+0.760 - TradingKey
Penumbra Market Sentiment - Benzinga España
WHITEBOX ADVISORS LLC's Penumbra Inc(PEN) Holding History - GuruFocus
Penumbra, Inc. (PEN) stock price, news, quote and history - Yahoo Finance Australia
Penumbra (PEN) Following THUNDERBOLT Debut, Is The Stock A Bargain Or Fairly Valued - Yahoo Finance
Penumbra (PEN) Wins FDA Clearance For THUNDERBOLT After Strong Stroke Study - Yahoo Finance
Penumbra, Inc. Revenue Breakdown – BMV:PEN - TradingView
Penumbra, Inc. (PEN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Magnendo Corp. announced that it has received $18 million in funding from Penumbra, Inc. and other investors - marketscreener.com
Magnendo Secures $18M Series A Financing to Transform Endovascular Access for Stroke Intervention - The Manila Times
Penumbra Inc (PEN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Penumbra stock reflects growth ambitions amid recent revenue gains - Ad-hoc-news.de
SA JPMorgan Mid-Cap Growth Portfolio's Penumbra Inc(PEN) Holding History - GuruFocus
Penumbra (PEN) Reports THUNDERBOLT Study Success As First Stroke Treatment Use Begins - Sahm
Morningstar Alternatives Fund's Penumbra Inc(PEN) Holding History - GuruFocus
Penumbra’s Thunderbolt stroke device meets study goals By Investing.com - Investing.com South Africa
Penumbra reports THUNDER study results for THUNDERBOLT stroke device - Bitget
Penumbra (PEN) Reports Promising Results for THUNDERBOLT Thrombe - GuruFocus
Penumbra’s Thunderbolt stroke device meets study goals - Investing.com
THUNDER Study Demonstrates Penumbra's THUNDERBOLT is Safe and Effective for Stroke Care - AOL.com
ETFs Investing in Penumbra, Inc. Stocks - TradingView
PEN stock trades steady as Penumbra focuses on growth after recent quarter - Ad-hoc-news.de
Penumbra, Inc. (PEN) Stock forecasts - Yahoo Finance UK
3 Medical Device Stocks Giving Investors a Different Healthcare Play - MarketBeat
Penumbra’s FORWARD Real‑World Stroke Study Might Change The Case For Investing In Penumbra (PEN) - Sahm
Penumbra Inc. Q1 2026 Earnings: EPS Misses Estimates Amid Challenging QuarterMargin Guidance - dars.gov.et
Penumbra Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
Penumbra (PEN) Starts The FORWARD Study, Is The Stock Already Expensive? - Sahm
Risk of Antitrust Challenges Remains Low for Boston's Acquisition of Penumbra - Morningstar
Penumbra Inc. (PEN) Q1 2026 Earnings: EPS Misses Estimates by 24.49%, Stock Inches UpCore Business Growth - dars.gov.et
Thunderbolt Computer-Assisted Vacuum Thrombectomy (CAVT) Platform, US - Medical Device Network
Analysts Conflicted on These Healthcare Names: Irhythm Technologies (IRTC), Penumbra (PEN) and Evolus (EOLS) - The Globe and Mail
Penumbra (PEN) Stock Forum and Discussion - Moomoo
(PEN) Volatility Zones as Tactical Triggers - Stock Traders Daily
Price to earnings forward of Penumbra, Inc. – MUN:0P8 - TradingView
Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT - AOL.com
Enterprise value to EBITDA forward of Penumbra, Inc. – NYSE:PEN - TradingView
Penumbra Deadline Alert - TMX Newsfile
Penumbra starts trial of clot removal device in stroke subgroup - MedTech Dive
Penumbra Inc. (PEN) Holds Steady Near $317 as Traders Eye Key ResistanceAAII Bearish - DonanımHaber
What Is Driving Penumbra (NYSE:PEN) on the NYSE Composite? - Kalkine Media
Penumbra enrolls first patient in distal acute stroke thrombectomy study - MassDevice
Penumbra initiates study on stroke treatment for distal occlusions - Investing.com
First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke - BioSpace
Penumbra initiates study on stroke treatment for distal occlusions By Investing.com - Investing.com Nigeria
Penumbra (PEN) Launches FORWARD Study to Assess Stroke Treatment Methods - GuruFocus
Penumbra enrolls first patient in stroke study for M2 occlusions - Stock Titan
GuideAI Health Appoints Renowned Interventional Radiologist Dr. James Benenati to Advisory Board Following FDA 510(k) Clearance of VAOT - GlobeNewswire Inc.
Penumbra, Inc. (PEN) Stock Analysis: A Healthcare Innovator with a 14.40% Potential Upside - DirectorsTalk Interviews
PENPenumbra Inc Volatility & Greeks - Finviz
0.79%
4.39%
大文字化:
|
ボリューム (24 時間):